Clinical Diagnosis and Treatment of Immune-related Adverse Events of Edocrine System Related to Immune Checkpoint Inhibitors

Clinical Diagnosis and Treatment of Immune-related Adverse Events of Edocrine System Related to Immune Checkpoint Inhibitors

As a new type of anti-cancer drugs, immune checkpoint inhibitors (ICIs) have shown remarkable therapeutic effects in many malignant tumors. By virtue of their targets and mechanisms of action, ICIs can cause autoimmune and inflammatory effects, termed immune-related adverse events (irAEs). Unlike tr...

Full description

Bibliographic Details
Main Authors: Lian DUAN, Linjie WANG, Xiaoyan SI, Li ZHANG, Xiaowei LIU, Yue LI, Hanping WANG, Xiaoxiao GUO, Jiaxin ZHOU, Huijuan ZHU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
Immune checkpoint inhibitors
Immune-related adverse events
Endocrine system
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.08

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.08

Similar Items